To assess the relative importance of the extent and regional distribution of fat for metabolic risk factors in young adults. DESIGN: Cross-sectional study of findings from a hospital-based case-control study. SUBJECTS: A total of 46 adult Danish Caucasian patients (40 men and six women, aged 34-54 y). Of these, 22 had had non fatal acute myocardial infarction before 41 y of age and 24 were age-and gender-matched controls without coronary heart disease. MEASUREMENTS: Four measurements of fat: body mass index (BMI, kg/m 2 ), body fat percentage measured using a dual energy X-ray absorptiometry (DEXA) scanner, waist/hip circumference ratio (WHR), and intra-abdominal adipose tissue area measured using computed tomography (CT) scanning, and eight metabolic risk factors: systolic and diastolic blood pressure, HbA 1c percentage, fasting concentrations of capillary whole blood glucose, high-density lipoprotein (HDL) cholesterol, serum triglyceride, plasma plasminogen activator inhibitor 1 (PAI-1), and urinary albumin:creatinine excretion ratio. RESULTS: Of 46 participants, 10 were obese (BMI 430 kg/m 2 ), 12 were abdominally obese (WHR 40.90 for men and 40.85 for women), and 20 were intra-abdominally obese (intra-abdominal adipose tissue area 4135 cm 2 ). Men had a higher intraabdominal adipose tissue area than women (P ¼ 0.0053, Mann-Whitney U-test). In multiple regression analyses of the four fat variables, only intra-abdominal adipose tissue area significantly predicted the levels of six metabolic risk factors: systolic blood pressure, diastolic blood pressure, fasting concentrations of capillary whole blood glucose, serum HDL cholesterol, serum triglyceride, and PAI-1. The intra-abdominal adipose tissue area had a linear relation with the six metabolic risk factors. CONCLUSIONS: For young individuals, intra-abdominal fat is the important component of the body fat for six of the eight metabolic risk factors. Intra-abdominal fat might contribute to that most patients with acute myocardial infarction at a young age are men. Overall, obesity is an excess of total body fat and may be diagnosed as a high BMI (Z30 kg/m 2 ). However, a dual energy X-ray absorptiometry (DEXA) scanner measures the body fat mass more precisely as a percentage of the weight of the body.
Introduction
Eventhough obesity is an established coronary risk factor, obesity measured as body mass index (BMI) was not a statistically significant major coronary risk factor in a Danish case-control study of acute myocardial infarction before the age of 41 y. 1 In this and a following second Danish casecontrol study, 90% of the patients with acute myocardial infarction at a young adult age were men. 2 An explanation for the two observations could be that a male ('android') distribution of the body fat was more important than the overall body fat measured as BMI. 3 Abdominal fat has been linked to metabolic risk factors like high systolic blood pressure, atherogenic dyslipidemia with increased serum triglyceride and decreased HDL cholesterol, glucose intolerance, and abnormalities in the coagulation system, 4 all factors that contribute to the coronary risk.
Overall, obesity is an excess of total body fat and may be diagnosed as a high BMI (Z30 kg/m 2 ). However, a dual energy X-ray absorptiometry (DEXA) scanner measures the body fat mass more precisely as a percentage of the weight of the body. 5 Abdominal obesity may be diagnosed as a high waist/hip circumference ratio (WHR) that can be because of an excess of either subcutaneous or intra-abdominal fat. A computed tomography (CT) scanning gives a more precise measure of the extent of the abdominal fat, and allows separate measurements of the subcutaneous and intraabdominal adipose tissue. 5 Furthermore, World Health
Organization (WHO) developed criteria for a metabolic syndrome including insulin resistance, overall obesity measured as BMI or abdominal obesity measured as WHR, and raised the levels of at least three of five metabolic risk factors. 6 There is no consensus as to the importance of the different measurements of body fat. 7 Therefore, we explored the relation between extent and regional distribution of body fat and metabolic risk factors based on the findings from the second Danish case-control study. The study included four measurements of extent and regional distribution of the body fat and eight metabolic risk factors. The aims of the present cross-sectional study were to evaluate whether (1) recorded background factors were important for the excess and localization of the body fat, (2) the extent and localization of the body fat was important for the metabolic risk factors, (3) intra-abdominal obesity related to the metabolic syndrome, and (4) whether intra-abdominal obesity might contribute to the gender difference for acute myocardial infarction at a young age. ). Written informed consent was obtained from all participants. The Science-Ethics Committee of Ringkoebing County had approved the study, and the Danish Register Board had approved the database for the study.
Subjects and methods

Study population
Examinations
All participants answered questionnaire forms with the same questions regarding family history for premature acute myocardial infarction, social class, and daily smoking and intake of alcohol. 'The questionnaire part of the study was undertaken in 1997 for the cases and in 1998 for the controls. Cases recorded the status before the acute myocardial infarction, and controls recorded that status corresponding to the time of the acute myocardial infarction for the matching case.
Furthermore, all participants underwent the same anthropometric, radiologic, and biochemical measurements during a 9-month period in 1999. We measured height and weight of the participants and considered those with BMI o25 kg/ m 2 as normal weight, those with BMI 25-30 kg/m 2 as overweight, and those with BMI 430 kg/m 2 as obese. One investigator (GD) measured the waist and hip circumferences while the participants were standing and wearing only light clothes. The circumferences were measured to the nearest 1.0 cm. The waist circumference was measured at a level midway between the lowest lateral border of the ribs and the uppermost lateral iliac crest, and the hip circumference was measured as the widest over the femoral great trochanters. According to WHO criteria, waist-to-hip ratios (WHR) 40.9 in men and 40.85 in women denote abdominal obesity. 6 A waist circumference 41.00 m was used to indicate intraabdominal obesity. The relative weights of the total fat and lean body tissue were measured using a single DEXA scanner (DPX-L, Lunar Corporation, Madison, WI, USA). The machine was regularly calibrated with a phantom. The participants were examined in a supine position. We evaluated the relative extent of fat as the fat percentage of total body weight and used 30% as upper cut off limit for reference values.
The extent of the intra-abdominal adipose tissue was measured in a CT scan with an abdominal slice at the level of the intervertebral space between the second and third lumbar vertebrae using a single Picker 2000 CT scanner. All participants but three underwent a CT scan. Slices were obtained with an exposure time of 1 s/section, 130 kV, slice thickness 1.0 cm, picture size 48 cm full field. One investigator (PM) marked the middle of the rectal abdominal muscles on the abdominal slices to separate subcutaneous and intra-abdominal regions. The attenuation interval between À140 and À40 Hounsfield units was set to indicate adipose tissue, and a Voxel Q (Picker International Inc., OH, Intra-abdominal obesity and metabolic risk factors FE von Eyben et al USA) calculated the extent of the subcutaneous and intraabdominal adipose tissue areas. We used the median value for the intra-abdominal adipose tissue area in men (135 cm 2 ) as cutoff limit to indicate intra-abdominal obesity.
The participants had fasted for at least 8 h before blood samples were obtained for the biochemical measurements. Blood samples were obtained between 8:00 and 9:00 h, drawn from an antecubital vein. Samples for fasting capillary whole blood glucose level were drawn in plastic tubes, hemolyzed immediately, and measured on a hemocue apparatus using a hexokinase method. Samples for HbA 1c were drawn in ethylene diaminetetraacetic acid (EDTA) vacutainer tubes and were measured using an immunoturbidimetric method on a Cobas Integra 700 apparatus (Roche Diagnostics, mean reference value 5.12, 95% reference interval 4.48-5.76%, s.d. 0.32%). Serum HDL cholesterol level was measured on a Cobas Integra 700 apparatus (Roche Diagnostics). Plasma plasminogen activator inhibitor 1 activity (PAI-1) was measured with a chromogenic method according to Behring Diagnostics, Marburg, Germany (80% reference interval 0.3-3.5 kU/l). Urinary albumin level was measured on a Cobas Integra 700 instrument using an immunoturbidimetric method and reagents from DAKO, Denmark, after urinary tract infection was excluded by stix. Levels of serum cholesterol and serum triglyceride were measured on a Vitros 950 apparatus (Kodak Ektachem, Germany). Most analytes were measured at Herning Central Hospital whereas PAI-1 was measured at the Center for Thrombosis Research at Braedstrup Hospital.
A raised fasting capillary whole blood glucose level Z6.1 mmol/l indicates diabetes according to the 1997 criteria by the American Diabetes Association. Participants with a raised fasting glucose or HbA 1c 46.1% were considered to have an impaired glucose homeostasis. The WHOs criteria for the metabolic syndrome were modified as the presence of impaired glucose homeostasis combined with two of four features: (1) BMI 430 kg/m 2 or WHR 40.9
in men and 40.85 in women; (2) systolic blood pressure Z160 mmHg or medication; (3) urinary albumin:creatinine ratio Z20 mg/g; and (4) triglyceride level Z1.7 mmol/l, or HDL cholesterol level o0.9 mmol/l in men and o1.0 mmol/l in women. 7 
Statistical analyses
For missing data, for example, history of use of alcohol for two cases, CT scans for two cases and one control, and measured HbA 1c for two controls, we substituted the median value of the variable for cases and controls, respectively. We used nonparametric statistics, for example, Fisher's exact test, Mann-Whitney U-test, and Spearman's rank correlation coefficient test, and the software programs SPSS 10.1 and STATA 7.0. All tests were two-sided, and a P-value o0.05 was considered statistically significant. The influence of several independent variables (eg, four fat variables) on a dependent variable (eg a metabolic risk factor) was studied using multiple regression analyses with backward elimination of independent variables. Variables with P-values 40.05 were excluded in the regression models. At each step in the backward regression analyses, we removed the variable with the smallest contribution to the model and the largest Pvalue. Despite the small sample size, evaluation of four independent variables in the regression analyses was acceptable as the ratio between the number of individuals and the number of examined independent variables was 410.
Results
Background factors and body fat
At the time of the present study, neither cases nor controls had known diabetes mellitus. Cases and controls did not differ significantly regarding BMI, body fat percentage, WHR, subcutaneous abdominal fat, intra-abdominal fat, and most recorded metabolic risk factors (Table 1) . Therefore, we combined the two groups of participants in the present analyses. (Figure 1 ). Furthermore, none of the women were intra-abdominally obese. BMI and heavy smoking were associated with intra-abdominal obesity whereas abdominal obesity was not (P ¼ 0.51, Fisher's exact test) ( for an increase of 1 kg/m 2 BMI, and was 55 cm 2 larger for men than for women. Intra-abdominal obesity was rare among participants with a normal BMI but present in half the overweight participants and most obese participants (Table 2) . Waist circumference correlated with the intra-abdominal adipose tissue area (Table 2) . However, a waist circumference 41.00 m did not include 12 of 20 (60%) participants with Intra-abdominal obesity and metabolic risk factors FE von Eyben et al intra-abdominal obesity and seven of nine (78%) with the metabolic syndrome.
Body fat and metabolic risk factors
Evaluating four fat variables, BMI, body fat percentage, WHR, and intra-abdominal adipose tissue area, in multiple regression analyses, only the last variable had a significant impact on six of eight metabolic risk factors. The significance of the association between intra-abdominal adipose tissue area and metabolic risk factors did not change as we adjusted the regression analyses for the impact from gender or age. A history of acute myocardial infarction had an impact on serum triglyceride but not on the five other metabolic risk factors. The formulas for the regression lines are:
Systolic blood pressure (mmHg) ¼ 126+0.14 (intra-abdominal adipose tissue area (cm Cases had a triglyceride level that was 0.74 mmol/l higher than that of the controls. For PAI-1, we evaluated the impact of background variables like smoking and alcohol intake, the obesity variables, and The four measurements of obesity did not have a significant association with HbA 1c and urinary albumin: creatinine excretion ratio. The subcutaneous abdominal adipose tissue area did not have a significant association with the metabolic risk factors. 
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Metabolic risk factors and the metabolic syndrome A total of 13 participants had impaired glucose homeostasis, and nine of these participants had the metabolic syndrome. The 46 participants had raised levels of PAI-1 and triglyceride more often than raised levels of systolic blood pressure and urinary albumin:creatinine excretion ratio judged by the WHO criteria for the syndrome (Table 1) . Intra-abdominal obesity associated significantly with raised levels for two metabolic risk factors according to the WHO criteria for the metabolic syndrome, fasting capillary whole blood glucose and triglyceride, as well as the metabolic syndrome itself. However, intra-abdominal obesity did not relate significantly with three other metabolic risk factors in the WHO criteria for the metabolic syndrome: systolic blood pressure, HDL cholesterol, and urinary albumin:creatinine excretion ratio (Table 2 ). In contrast, intra-abdominal obesity significantly associated with raised levels of five metabolic risk factors that were not included in the WHO criteria for the metabolic syndrome: systolic blood pressure according to a cut off limit of 130 mmHg, diastolic blood pressure, HbA 1c , glucose homeostasis, and PAI-1.
Discussion
To our knowledge, this is the first cross-sectional study reporting the four measurements of body fat in relation to eight metabolic risk factors and the metabolic syndrome. Intra-abdominal fat was body fat component that was most important for the metabolic risk factors. In multiple regression analyses of the four measures of body fat, only intraabdominal adipose tissue was significantly associated with six metabolic risk factors. Men had a higher intra-abdominal Intra-abdominal obesity and metabolic risk factors FE von Eyben et al adipose tissue area than women, and the intra-abdominal adipose tissue area rose nonlinearly with a rise in BMI. All other fat measurements including that of the subcutaneous abdominal adipose tissue area did not relate significantly with the eight measured metabolic risk factors. Only few data were missing in the study regarding alcohol intake, CT scans, and HbA 1c . Graphical presentation of the cases and controls supported the multiple regression analyses in that the status as case and control only influenced the level of triglyceride, but not the other five metabolic risk factors.
The findings add to the evidence of previous publications. They showed a similar relation between gender, BMI, and intra-abdominal adipose tissue area. 8, 9 WHR is widely used as a measurement of the extent of the abdominal fat, 7 but the ratio has several limitations. In the present study, it differed less between the two genders than the intra-abdominal fat area, and did not indicate intra-abdominal obesity based on the cutoff limit of the WHO criteria for the metabolic syndrome. In another study, it did not reflect how intraabdominal adipose tissue changed during follow-up. 10 Many cohort studies support that abdominal obesity is a more important metabolic risk factor than overall obesity, [11] [12] [13] [14] with some exceptions. 15 According to our findings, abdominal obesity might have been an even more important risk factor in these studies if they had measured it as the extent of the intra-abdominal fat. Intra-abdominal adipose tissue area had overall linear relations with the six metabolic risk factors, and the regression analyses ascribed 13-20% of the variation in blood pressure to the variation in extent of the intraabdominal adipose tissue. The linear relations suggest that intra-abdominal fat has a biologic link to the level of these metabolic risk factors. Previous studies analyzed three groups according to BMI (lean, overweight, and obese individuals) and found a significant association between the intraabdominal adipose tissue area and levels of fasting blood glucose, HDL cholesterol, and serum triglyceride only for those with overweight and obesity. 8, 9, [16] [17] [18] [19] For our participants, an intra-abdominal adipose tissue area 4135 cm 2 pointed out raised levels of metabolic risk factors. Similarly, Despres and Marette 4 found that an intra-abdominal adipose tissue area of 130 cm 2 on a CT scan was a useful cut off limit to indicate intra-abdominal obesity. It has been argued that waist circumference with a cutoff limit of 1.00 m should be preferred for a CT scanning of the abdomen as a measure to indicate intra-abdominal obesity. 4, 6 Nevertheless in our study, waist circumference was a poor substitute for the intra-abdominal adipose tissue: Use of only a high waist circumference excluded 60% of our participants with intra-abdominal obesity and 78% of those with the metabolic syndrome. Similarly in a Finnish study, WHR was somewhat stronger than waist circumference in indicating coronary risk. 20 Even worse, as a US study used waist to indicate abdominal fat, more women than men were abdominally obese. 21 Overall, obesity has been linked to high systolic blood pressure, high levels of fasting glucose, triglyceride, and low levels of HDL cholesterol in previous reviews. 7 However in our multivariate analyses and other studies, overall body fat had no significant association with metabolic risk factors whether it was measured directly as body fat percentage or indirectly as BMI. 16, 19 The previous studies measured the body fat percentage using hydrostatic weighing so the lack of impact from body fat percentage was independent of the method used for the measurement. Thus, overall body fat might have only an indirect impact on the metabolic risk factors reflecting the association between overall body fat and the intra-abdominal fat.
Another study also found an association between intraabdominal fat and PAI-1, 22 whereas smoking, alcohol intake, and BMI was associated with PAI-1 in a Japanese study, but it did not measure the intra-abdominal adipose area.
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The association between intra-abdominal obesity and fasting glucose and the features of the metabolic syndrome may be mediated through insulin resistance. In accordance with our findings, another recent study found that many patients with acute myocardial infarction had undiagnosed type-II diabetes. 24 Seven of our 22 cases (32%) fulfilled modified criteria for the metabolic syndrome. Similarly, 29% of a Canadian series of patients with premature coronary disease had the metabolic syndrome. 25 In the Finnish Kuopio Ischaemic Heart Disease study, 8-14.3% of middleaged men had the metabolic syndrome, depending on the criteria for the syndrome. 26 It also predicted development of coronary heart disease both in this study and in the Finnish Botnia study. 27 Nevertheless, our findings showed a poor consistency between intra-abdominal obesity and the metabolic syndrome as defined by WHO: Intra-abdominal obesity did not relate to three metabolic risk factors according to the cut off limits in the WHO definition of the syndrome: systolic blood pressure, HDL cholesterol, and urinary albumin:creatinine excretion ratio. 7 In contrast, a relation was found to five other metabolic risk factors: systolic blood pressure using 130 mmHg as cut off limit, diastolic blood pressure, HbA 1c , glucose homeostasis, and PAI-1. In Adult Treatment Panel III by the National Cholesterol Education Program, metabolic syndrome was defined as any three of five risk factors: waist circumference 4102 cm in men and 488 cm in women, blood pressure Z130/Z85 mmHg, triglyceride Z150 mg/dl (Z1-7 mmol/l), HDL cholesterol o40 mg/dl (o1.04 mmol/l) in men and o50 mg/dl (o1.30 mmol/l) in women, and fasting plasma glucose Z110 mg/dl (Z6.1 mmol/l, or Z5.6 mmol/l blood glucose). 28 The present findings were more consistent with this set of criteria for the metabolic syndrome. Similarly, the European Group for the study of Insulin Resistance modified the WHO definition of the metabolic syndrome to hyperinsulinemia or elevated fasting glycemia, and at least two of the following: abdominal obesity, dyslipidemia, and hypertension. 29 Intra-abdominal obesity and metabolic risk factors FE von Eyben et al Previously, the male predominance for acute myocardial infarction for young adults has been ascribed to a protection of women from estrogens, but several observations do not fit with this explanation. Neither for men nor for postmenopausal women, treatment with estrogen with or without progestin gave protection against coronary events.
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Therefore, the higher coronary risk of men may be because of other risk factors. Men have lower levels of HDL cholesterol than premenopausal women, 33 but the intraabdominal adipose tissue may contribute even more to the male predominance regarding acute myocardial infarction at a young age. First, most of the gender differences in the levels of serum HDL cholesterol may reflect that the genders differ in the extent of intra-abdominal fat. 34 Secondly in our study, only men had intra-abdominal obesity. Furthermore, cases had higher levels of serum triglyceride for a given extent of intra-abdominal adipose tissue area than controls. Our findings have implications for public health. Measurements of the intra-abdominal adipose tissue should be used widely in studying the metabolic risk from obesity and for primary prevention of cardiovascular disease and type-II diabetes. In contrast, guidelines from the US National Heart, Blood and Lung Institute discouraged that obesity is measured as intra-abdominal fat area, and argued that CT scannings were expensive and exposed to irradiation, and that facilities for the scannings were unavailable for routine use. 7 We do not agree. A single slice on an abdominal CT scan may not cost more than the expenses that have been accepted in connection with other investigations of metabolic risk. Furthermore, CT scanners of today give a lower dosage of irradiation for an abdominal examination than those of the past, and are widely accessible in Western countries. In fact, CT scanners are more widely available than facilities for a measurement of insulin resistance, a WHO criterion for the metabolic syndrome, or of insulin. The study has several limitations. It matched cases and controls for gender, so it included only few women and had a higher proportion of patients surviving acute myocardial infarction than the age group has in general. Controls were overweight more often than the background population from which they were selected. We did not include an oral glucose tolerance test but recommended participants with impaired glucose homeostasis to contact their primary physicians for further examinations. By design, a crosssectional study does not prove causality for the statistically significant associations between the studied variables.
Large prospective studies are warranted to further elucidate how intra-abdominal fat relate to serum triglyceride and coronary risk, and to validate the link between the relatively high level of intra-abdominal fat in men and the male predominance for acute myocardial infarction at a young age. Further studies are also indicated to evaluate whether intra-abdominal adipose tissue area has a cause-effect relation with metabolic risk factors and coronary heart disease, for example, using interventions to reduce intraabdominal adipose tissue. The radiation dose from a single abdominal slice by a modern CT scanner should be calculated and reported.
For young individuals, intra-abdominal fat is the most important component of the body fat in relation to metabolic risk factors. Intra-abdominal fat might contribute to that most patients with acute myocardial infarction at a young age are men.
